Characterization of corticotropin-releasing hormone (CRH) in human skin

J Clin Endocrinol Metab. 1998 Mar;83(3):1020-4. doi: 10.1210/jcem.83.3.4650.

Abstract

We have confirmed the expression of CRH and CRH receptor type 1 genes in human skin, cultured HaCaT keratinocytes, squamous cell carcinoma, and melanoma cells. The size of CRH messenger ribonucleic acid (mRNA), estimated by Northern blot hybridization, was 1.5 kilobases. CRH peptide was identified by reverse phase high pressure liquid chromatography separation in both whole skin and cultured cells. Forskolin and dexamethasone at concentrations of 10 micromol/L stimulated and inhibited, respectively, CRH peptide production in squamous cell carcinoma and melanoma cells, but had no significant effect on the CRH mRNA level. In melanoma cells, stimulation of melanogenesis down-regulated CRH receptor type 1 mRNA expression, but was without effect on CRH mRNA production. We suggest that in human skin the CRH signaling system is both operative and under regulatory control.

Publication types

  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Blotting, Northern
  • Carcinoma, Squamous Cell / metabolism
  • Carcinoma, Squamous Cell / pathology
  • Cells, Cultured
  • Chromatography, High Pressure Liquid
  • Colforsin / pharmacology
  • Corticotropin-Releasing Hormone / genetics
  • Corticotropin-Releasing Hormone / metabolism*
  • Dexamethasone / pharmacology
  • Down-Regulation
  • Glucocorticoids / pharmacology
  • Humans
  • Melanins / biosynthesis
  • Melanoma / metabolism
  • Melanoma / pathology
  • RNA, Messenger / metabolism
  • Receptors, Corticotropin-Releasing Hormone / genetics
  • Receptors, Corticotropin-Releasing Hormone / metabolism
  • Skin / metabolism*
  • Skin Neoplasms / metabolism
  • Skin Neoplasms / pathology

Substances

  • Glucocorticoids
  • Melanins
  • RNA, Messenger
  • Receptors, Corticotropin-Releasing Hormone
  • Colforsin
  • Dexamethasone
  • Corticotropin-Releasing Hormone